{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:16:21Z","timestamp":1791270981243,"version":"4.1.0"},"reference-count":156,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00707","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:31:01Z","timestamp":1588915861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Muscle-Specific Kinase Myasthenia Gravis"],"prefix":"10.3389","volume":"11","author":[{"given":"Lucia S.","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Richman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0852-4","article-title":"Congenital myasthenic syndromes in 2018.","volume":"18","author":"Engel","year":"2018","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061677","article-title":"The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes.","volume":"19","author":"Rodriguez Cruz","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetylcholine receptors and myasthenia.","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve."},{"key":"B4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2008-1041066","article-title":"Myasthenia gravis: pathogenesis and treatment.","volume":"14","author":"Richman","year":"1994","journal-title":"Semin Neurol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse.","volume":"190","author":"Toyka","year":"1975","journal-title":"Science."},{"key":"B6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/285238a0","article-title":"Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.","volume":"285","author":"Lennon","year":"1980","journal-title":"Nature."},{"key":"B7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/286738a0","article-title":"Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia.","volume":"286","author":"Richman","year":"1980","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor.","volume":"180","author":"Patrick","year":"1973","journal-title":"Science."},{"key":"B10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1749-6632.1998.tb10962.x","article-title":"Antibody effector mechanisms in myasthenia gravis. The complement hypothesis.","volume":"841","author":"Richman","year":"1998","journal-title":"Ann N Y Acad Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0038-1660500","article-title":"Pathogenic mechanisms and clinical correlations in autoimmune myasthenic syndromes.","volume":"38","author":"Cetin","year":"2018","journal-title":"Semin Neurol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/mus.880141208","article-title":"Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studies.","volume":"14","author":"Maselli","year":"1991","journal-title":"Muscle Nerve."},{"key":"B13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1749-6632.1976.tb47676.x","article-title":"The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.","volume":"274","author":"Engel","year":"1976","journal-title":"Ann N Y Acad Sci."},{"key":"B14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med."},{"key":"B15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1432-1327.1998.2530382.x","article-title":"Tyrosine phosphorylation of the muscle-specific kinase is exclusively induced by acetylcholine receptor-aggregating agrin fragments.","volume":"253","author":"Hopf","year":"1998","journal-title":"Eur J Biochem."},{"key":"B16","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1073\/pnas.90.7.2895","article-title":"Muscle-specific trk-related receptor with a kringle domain defines a distinct class of receptor tyrosine kinases.","volume":"90","author":"Jennings","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmb.2009.07.091","article-title":"Crystal structure of the frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK.","volume":"393","author":"Stiegler","year":"2009","journal-title":"J Mol Biol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury.","volume":"15","author":"Valenzuela","year":"1995","journal-title":"Neuron."},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0166-2236(96)10066-7","article-title":"Genes at the junction\u2013candidates for congenital myasthenic syndromes.","volume":"20","author":"Vincent","year":"1997","journal-title":"Trends Neurosci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020490","article-title":"Fundamental molecules and mechanisms for forming and maintaining neuromuscular synapses.","volume":"19","author":"Burden","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009167","article-title":"The role of MuSK in synapse formation and neuromuscular disease.","volume":"5","author":"Burden","year":"2013","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/neu.10137","article-title":"Building the vertebrate neuromuscular synapse.","volume":"53","author":"Burden","year":"2002","journal-title":"J Neurobiol."},{"key":"B23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nn0703-653","article-title":"Agrin\/MuSK signaling: willing and Abl.","volume":"6","author":"Burden","year":"2003","journal-title":"Nat Neurosci."},{"key":"B24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.20440","article-title":"Molecular architecture of the neuromuscular junction.","volume":"33","author":"Hughes","year":"2006","journal-title":"Muscle Nerve."},{"key":"B25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/35097557","article-title":"Induction, assembly, maturation and maintenance of a postsynaptic apparatus.","volume":"2","author":"Sanes","year":"2001","journal-title":"Nat Rev Neurosci."},{"key":"B26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/35074025","article-title":"Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse.","volume":"410","author":"Lin","year":"2001","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0896-6273(01)00287-2","article-title":"Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation.","volume":"30","author":"Yang","year":"2001","journal-title":"Neuron."},{"key":"B28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nn.2792","article-title":"Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors.","volume":"14","author":"Chen","year":"2011","journal-title":"Nat Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle specific kinase: organiser of synaptic membrane domains.","volume":"43","author":"Ghazanfari","year":"2011","journal-title":"Int J Biochem Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1101\/gad.1977710","article-title":"Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.","volume":"24","author":"Hallock","year":"2010","journal-title":"Genes Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1748-1716.2011.02295.x","article-title":"Dual roles for Wnt signalling during the formation of the vertebrate neuromuscular junction.","volume":"204","author":"Henriquez","year":"2011","journal-title":"Acta Physiol (Oxf)."},{"key":"B32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0166-2236(03)00131-0","article-title":"Molecular dissection of neuromuscular junction formation.","volume":"26","author":"Hoch","year":"2003","journal-title":"Trends Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost.","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr Opin Neurobiol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.20-10-03663.2000","article-title":"From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction.","volume":"20","author":"Marques","year":"2000","journal-title":"J Neurosci."},{"key":"B35","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1242\/dev.02044","article-title":"Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations.","volume":"132","author":"Flanagan-Steet","year":"2005","journal-title":"Development."},{"key":"B36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ydbio.2005.06.027","article-title":"Neuromuscular synaptogenesis in wild-type and mutant zebrafish.","volume":"285","author":"Panzer","year":"2005","journal-title":"Dev Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK.","volume":"135","author":"Kim","year":"2008","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction.","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development."},{"key":"B39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin.","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron."},{"key":"B40","doi-asserted-by":"publisher","first-page":"11468","DOI":"10.1523\/JNEUROSCI.2508-08.2008","article-title":"Identification of a motif in the acetylcholine receptor beta subunit whose phosphorylation regulates rapsyn association and postsynaptic receptor localization.","volume":"28","author":"Borges","year":"2008","journal-title":"J Neurosci."},{"key":"B41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0896-6273(90)90049-L","article-title":"Regulation of tyrosine phosphorylation of the nicotinic acetylcholine receptor at the rat neuromuscular junction.","volume":"4","author":"Qu","year":"1990","journal-title":"Neuron."},{"key":"B42","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1073\/pnas.95.7.4007","article-title":"Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn.","volume":"95","author":"Ramarao","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.","volume":"312","author":"Okada","year":"2006","journal-title":"Science."},{"key":"B44","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1083\/jcb.150.6.1321","article-title":"The actin-driven movement and formation of acetylcholine receptor clusters.","volume":"150","author":"Dai","year":"2000","journal-title":"J Cell Biol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/bies.20305","article-title":"The synaptic muscle-specific kinase (MuSK) complex: new partners, new functions.","volume":"27","author":"Strochlic","year":"2005","journal-title":"Bioessays."},{"key":"B46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuron.2005.04.002","article-title":"Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism.","volume":"46","author":"Lin","year":"2005","journal-title":"Neuron."},{"key":"B47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0168-9525(93)90066-Q","article-title":"Synapse-specific gene expression.","volume":"9","author":"Burden","year":"1993","journal-title":"Trends Genet."},{"key":"B48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/317066a0","article-title":"Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibres.","volume":"317","author":"Merlie","year":"1985","journal-title":"Nature."},{"key":"B50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/BC20110018","article-title":"Agrin triggers the clustering of raft-associated acetylcholine receptors through actin cytoskeleton reorganization.","volume":"103","author":"Cartaud","year":"2011","journal-title":"Biol Cell."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008478","article-title":"The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction.","volume":"4","author":"Madhavan","year":"2009","journal-title":"PLoS One."},{"key":"B52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.","volume":"165","author":"Cartaud","year":"2004","journal-title":"J Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1523\/jneurosci.4374-09.2010","article-title":"ColQ controls postsynaptic differentiation at the neuromuscular junction.","volume":"30","author":"Sigoillot","year":"2010","journal-title":"J Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.mcn.2004.09.013","article-title":"Motor neurite outgrowth is selectively inhibited by cell surface MuSK and agrin.","volume":"28","author":"Dimitropoulou","year":"2005","journal-title":"Mol Cell Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses.","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature."},{"key":"B56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation.","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1083\/jcb.200401115","article-title":"Nerve-independent formation of a topologically complex postsynaptic apparatus.","volume":"164","author":"Kummer","year":"2004","journal-title":"J Cell Biol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1523\/JNEUROSCI.21-09-03151.2001","article-title":"Src, Fyn, and Yes are not required for neuromuscular synapse formation but are necessary for stabilization of agrin-induced clusters of acetylcholine receptors.","volume":"21","author":"Smith","year":"2001","journal-title":"J Neurosci."},{"key":"B59","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1113\/jphysiol.2013.270207","article-title":"Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.","author":"Ghazanfari","year":"2014","journal-title":"J Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1749-6632.2012.06782.x","article-title":"Animal models of antimuscle-specific kinase myasthenia.","volume":"1274","author":"Richman","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B62","article-title":"Acute severe model of anti-muscle specific kinase (MuSK) myasthenia in lewis rats (Abstract).","volume":"71","author":"Richman","year":"2008","journal-title":"Neurology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1001\/archneurol.2011.2200","article-title":"Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.","volume":"69","author":"Richman","year":"2012","journal-title":"Arch Neurol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.mcn.2005.10.020","article-title":"Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK.","volume":"31","author":"Hesser","year":"2006","journal-title":"Mol Cell Neurosci."},{"key":"B65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.embor.7400065","article-title":"Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference.","volume":"5","author":"Kong","year":"2004","journal-title":"EMBO Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamaneurol.2014.4740","article-title":"The future of research in myasthenia.","volume":"72","author":"Richman","year":"2015"},{"key":"B67","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jmb.2006.09.019","article-title":"Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK.","volume":"364","author":"Stiegler","year":"2006","journal-title":"J Mol Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"40624","DOI":"10.1074\/jbc.M111.279307","article-title":"Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).","volume":"286","author":"Zhang","year":"2011","journal-title":"J Biol Chem."},{"key":"B69","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1074\/jbc.273.11.6467","article-title":"Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes.","volume":"273","author":"Hopf","year":"1998","journal-title":"J Biol Chem."},{"key":"B70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nbt0897-768","article-title":"Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv.","volume":"15","author":"Xie","year":"1997","journal-title":"Nat Biotechnol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol Cell."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000113","article-title":"Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation.","volume":"2","author":"Inoue","year":"2009","journal-title":"Sci Signal."},{"key":"B73","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.neuron.2008.12.025","article-title":"Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged\/MuSK receptor.","volume":"61","author":"Jing","year":"2009","journal-title":"Neuron."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1523\/JNEUROSCI.3381-14.2015","article-title":"MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance.","volume":"35","author":"Messeant","year":"2015","journal-title":"J Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1101\/gad.279745.116","article-title":"Diverging roles for Lrp4 and Wnt signaling in neuromuscular synapse development during evolution.","volume":"30","author":"Remedio","year":"2016","journal-title":"Genes Dev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/humu.23949","article-title":"Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure.","volume":"41","author":"Rodriguez Cruz","year":"2020","journal-title":"Hum Mutat."},{"key":"B77","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol."},{"key":"B78","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.","author":"Evoli","year":"2003","journal-title":"Brain."},{"key":"B79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2006.10.004","article-title":"Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.","volume":"118","author":"Farrugia","year":"2007","journal-title":"Clin Neurophysiol."},{"key":"B80","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG.","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s1474-4422(03)00306-5","article-title":"Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.","volume":"2","author":"Vincent","year":"2003","journal-title":"Lancet Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.20069","article-title":"Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.","volume":"30","author":"Zhou","year":"2004","journal-title":"Muscle Nerve."},{"key":"B83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1196\/annals.1405.005","article-title":"Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.","volume":"1132","author":"Wolfe","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B84","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.crad.2007.05.003","article-title":"Magnetic resonance imaging of facial muscles.","volume":"62","author":"Farrugia","year":"2007","journal-title":"Clin Radiol."},{"key":"B85","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.","author":"Farrugia","year":"2006","journal-title":"Brain."},{"key":"B86","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2169\/internalmedicine.44.671","article-title":"Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis.","volume":"44","author":"Ishii","year":"2005","journal-title":"Intern Med."},{"key":"B87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.","volume":"170","author":"Benveniste","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis.","volume":"177","author":"Boneva","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B89","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.clinph.2006.12.018","article-title":"Turn\/amplitude analysis to assess bulbar muscle wasting in MuSK positive myasthenia.","volume":"118","author":"Finsterer","year":"2007","journal-title":"Clin Neurophysiol."},{"key":"B90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2990.2008.00965.x","article-title":"Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.","volume":"35","author":"Martignago","year":"2009","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00415-010-5823-x","article-title":"Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.","volume":"258","author":"Cenacchi","year":"2011","journal-title":"J Neurol."},{"key":"B92","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG): epidemiological data and prognostic factors.","volume":"998","author":"Mantegazza","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"B93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis.","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve."},{"key":"B94","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt Sinai J Med."},{"key":"B95","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands.","volume":"78","author":"Niks","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B96","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology."},{"key":"B97","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology."},{"key":"B98","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol."},{"key":"B99","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.65.5.782","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.","volume":"65","author":"Saka","year":"2005","journal-title":"Neurology."},{"key":"B100","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2013.12.007","article-title":"T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients.","volume":"52","author":"Marino","year":"2014","journal-title":"J Autoimmun."},{"key":"B101","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK.","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B102","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve."},{"key":"B103","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology."},{"key":"B104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann Neurol."},{"key":"B105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0960-8966(96)00009-0","article-title":"Clinical heterogeneity of seronegative myasthenia gravis.","volume":"6","author":"Evoli","year":"1996","journal-title":"Neuromuscul Disord."},{"key":"B106","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B107","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.","volume":"178","author":"Tao","year":"1993","journal-title":"J Exp Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.","author":"Klooster","year":"2012","journal-title":"Brain."},{"key":"B109","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbadis.2017.07.038","article-title":"On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease.","author":"Trampert","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.","volume":"77","author":"Koneczny","year":"2017","journal-title":"J Autoimmun."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis.","author":"Leite","year":"2008","journal-title":"Brain."},{"key":"B113","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2015.12.016","article-title":"Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.","volume":"291","author":"Huijbers","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling.","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci Rep."},{"key":"B115","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneuroim.2012.09.001","article-title":"Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis.","volume":"254","author":"Takamori","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.WNL.0000129702.41868.A5","article-title":"Is \u201cseronegative\u201d MG explained by autoantibodies to MuSK?","volume":"62","author":"Lindstrom","year":"2004","journal-title":"Neurology."},{"key":"B117","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase.","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J Clin Invest."},{"key":"B118","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol."},{"key":"B119","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK).","volume":"175","author":"Jha","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.","volume":"230","author":"Punga","year":"2011","journal-title":"Exp Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis.","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol."},{"key":"B122","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice.","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin Immunol (Orlando, Fla)."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110571","article-title":"Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis.","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One."},{"key":"B124","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.","author":"Cole","year":"2010","journal-title":"J Physiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.12.005","article-title":"Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.","volume":"244","author":"Mori","year":"2012","journal-title":"J Neuroimmunol."},{"key":"B126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level.","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann Neurol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14712590802588831","article-title":"A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis.","volume":"9","author":"Ponseti","year":"2009","journal-title":"Expert Opin Biol Ther."},{"key":"B128","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve."},{"key":"B129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","article-title":"Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.","volume":"23","author":"Guptill","year":"2010","journal-title":"Curr Opin Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve."},{"key":"B131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve."},{"key":"B132","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1212\/WNL.0b013e3182377fa6","article-title":"Myasthenia gravis with antibodies to MuSK: another step toward solving mystery?","volume":"77","author":"Evoli","year":"2011","journal-title":"Neurology."},{"key":"B133","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mus.26107","article-title":"Myasthenia gravis with muscle-specific tyrosine kinase antibodies: a narrative review.","volume":"58","author":"Morren","year":"2018","journal-title":"Muscle Nerve."},{"key":"B134","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/WCO.0000000000000136","article-title":"Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.","volume":"27","author":"Reddel","year":"2014","journal-title":"Curr Opin Neurol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update.","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-musk antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve."},{"key":"B137","first-page":"255","article-title":"Clinical characteristics of refractory myasthenia gravis patients.","volume":"86","author":"Suh","year":"2013","journal-title":"Yale J Biol Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CND.0000000000000034","article-title":"Treatment-refractory myasthenia gravis.","volume":"15","author":"Silvestri","year":"2014","journal-title":"J Clin Neuromuscul Dis."},{"key":"B139","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis.","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology."},{"key":"B140","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary.","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","article-title":"MuSK-antibody positive myasthenia gravis: questions from the clinic.","volume":"20","author":"Sanders","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review.","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology."},{"key":"B143","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/jnnp-2012-303664","article-title":"Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients.","volume":"84","author":"Keung","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B144","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2008.04.039","article-title":"Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.","volume":"20","author":"Illa","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia.","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"Neurology."},{"key":"B146","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/1756285611411503","article-title":"Response of patients with refractory myasthenia gravis to rituximab: a retrospective study.","volume":"4","author":"Nowak","year":"2011","journal-title":"Ther Adv Neurol Disord."},{"key":"B147","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/acn3.564","article-title":"The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.","volume":"5","author":"Cortes-Vicente","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B148","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002277.pub3","article-title":"Intravenous immunoglobulin for myasthenia gravis.","volume":"12","author":"Gajdos","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2169\/internalmedicine.9466-17","article-title":"Anti-MuSK antibody-positive Myasthenia Gravis successfully treated with outpatient periodic weekly blood purification therapy.","volume":"57","author":"Deguchi","year":"2018","journal-title":"Intern Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.nmd.2015.03.014","article-title":"Selective response to rituximab in a young child with MuSK-associated myasthenia gravis.","volume":"25","author":"Govindarajan","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B151","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jns.2006.05.065","article-title":"High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.","volume":"247","author":"Takahashi","year":"2006","journal-title":"J Neurol Sci."},{"key":"B152","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0404.2007.00877.x","article-title":"Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.","volume":"116","author":"Shibata-Hamaguchi","year":"2007","journal-title":"Acta Neurol Scand."},{"key":"B153","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1196\/annals.1405.017","article-title":"Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.","volume":"1132","author":"Tzartos","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B154","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s004150070149","article-title":"Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis.","volume":"247","author":"Yeh","year":"2000","journal-title":"J Neurol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molimm.2014.01.002","article-title":"Design, synthesis, and characterization of a 39 amino acid peptide mimic of the main immunogenic region of the Torpedo acetylcholine receptor.","volume":"59","author":"Trinh","year":"2014","journal-title":"Mol Immunol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:31:18Z","timestamp":1588915878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":156,"alternative-id":["10.3389\/fimmu.2020.00707"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00707","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"707"}}